Accord Healthcare
Privately held: no public share price · United Kingdom
Assets
(2 total)
2Total Assets
1Approved
1Phase 3 / Filed
0Phase 1–2 / Early
6Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | IL-12 p40Monoclonal antibody | Inflammatory Bowel DiseasePsoriatic ArthritisPsoriasis Ulcerative Colitis, Crohn's Disease | |
| Phase 3 | PD-1Monoclonal antibody | Non-Small Cell Lung CancerSmall Cell Lung CancerGastric Cancer |
Upcoming events
(5 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2027 (4)
May 2027 (1)
Est. primary completion 2027-05-15 · NCT07487519 · CT.gov ↗
What to watch
June 2027 (1)
Est. primary completion 2027-06-18 · NCT07253142 · CT.gov ↗
What to watch
July 2027 (1)
Est. primary completion 2027-07-28 · NCT07358585 · CT.gov ↗
What to watch
December 2027 (1)
Est. primary completion 2027-12-30 · NCT06857279 · CT.gov ↗
What to watch
2031 (1)
January 2031 (1)
Est. primary completion 2031-01 · NCT07318883 · CT.gov ↗
What to watch
Financial reports
No financial reports recorded.